[
    [
        {
            "time": "",
            "original_text": "年报里的医药增长密码：集采疫情内外因素跌宕 创新药时代来临18家药企研发增超100%",
            "features": {
                "keywords": [
                    "医药",
                    "增长",
                    "集采",
                    "疫情",
                    "创新药"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "年报里的医药增长密码：集采疫情内外因素跌宕 创新药时代来临18家药企研发增超100%",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "渤海证券给予乐普医疗增持评级，2020年年度报告及2021年一季报点评：创新引领发展，全面构建心血管平台型企业",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "增持",
                    "年度报告",
                    "一季报",
                    "创新",
                    "心血管"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渤海证券给予乐普医疗增持评级，2020年年度报告及2021年一季报点评：创新引领发展，全面构建心血管平台型企业",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "乐普医疗(300003)：创新引领发展 全面构建心血管平台型企业",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "创新",
                    "心血管",
                    "平台型"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗(300003)：创新引领发展 全面构建心血管平台型企业",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]